文献速递慢性静脉疾病

辅助技术减少微泡沫硬化剂治疗大隐静脉及属支后血栓并发症

Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-11-26

该回顾性研究纳入99例患者共129条肢体,评估术中辅助技术(抬高肢体>45°、超声定位压迫穿通静脉、限制泡沫量等)对Varithena微泡沫消融后血栓延伸的影响。结果显示即刻闭合率95%,症状缓解率81%,仅1.5%肢体需抗凝治疗深静脉血栓延伸,无肺栓塞及神经视觉不良事件。

要点

  • 微泡沫消融术中采用抬高肢体、压迫穿通静脉等辅助技术可降低深静脉血栓延伸风险。
  • 术后48-72小时双功超声监测是必要的,本组深静脉血栓延伸发生率为1.5%。
  • Varithena微泡沫消融是一种安全有效的非热非肿胀麻醉替代激光和射频消融的方法。

核心结论

  • 辅助技术可减少微泡沫消融后血栓并发症,早期闭合率和症状改善良好。
  • Varithena微泡沫消融是安全有效的非热非肿胀麻醉替代方法。

研究设计与样本

  • 回顾性分析前瞻性维护数据库,纳入99例患者共129条肢体。
  • 纳入标准为症状性浅静脉轴枝及属支反流接受Varithena微泡沫消融且完成术后48-72小时双功超声随访者。

主要发现

  • 治疗静脉包括大隐静脉89条、前副隐静脉15条、小隐静脉14条、属支静脉56条。
  • 术前静脉临床严重程度评分11.4,术后降至9.7;即刻闭合率95%,总体症状缓解率81%。
  • 2条肢体(1.5%)因血栓延伸至深静脉系统(股总静脉1条、腘静脉1条)需术后抗凝平均22天,均缓解。
  • 术后疼痛和血栓性静脉炎发生率分别为15.6%和14.8%,随访时均缓解;无肺栓塞及神经或视觉不良事件。

关键数值与推荐

  • 术中辅助技术包括:肢体抬高>45°、超声定位并数字压迫大穿通静脉、限制每次泡沫量、治疗前注射无菌生理盐水、抬高体位下压迫肢体。
  • 术后48-72小时双功超声扫描用于评估血栓延伸。

临床怎么用

  • 在微泡沫消融术中应用辅助技术(抬高肢体、压迫穿通静脉、限制泡沫量等)可降低深静脉血栓延伸风险。
  • 术后应常规行双功超声监测以早期发现深静脉血栓延伸。

局限性

  • 回顾性研究设计,样本量有限,随访时间较短(平均113.5天)。
  • 未与对照组比较,辅助技术的独立效应需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thrombus extension into the deep venous system following superficial vein chemical ablation with Varithena polidocanol microfoam has been reported. The objective of this study was to assess the effect of intraoperative improved techniques during treatment for patients with symptomatic varicose veins and their impact on extension of thrombus into deep veins. METHODS: A retrospective review of a prospectively maintained database was performed. All patients who underwent endovenous chemical ablation with polidocanol microfoam (Varithena, Boston Scientific, Marlborough, Mass) for symptomatic superficial axial and tributary vein reflux were identified. Patients had postoperative duplex (48-72 hours) scanning after the procedure; those who did not adhere to the recommended follow-up were excluded. Demographic data, CEAP Classification, Venous Clinical Severity Score, procedure details, and follow-up data were abstracted. RESULTS: Between April 2018 and August 2020, 157 limbs in 122 patients were treated with Varithena microfoam; 129 limbs in 99 patients met our inclusion criteria. Veins treated included the great saphenous vein (n = 89), anterior accessory saphenous vein (n = 15), small saphenous vein (n = 14), and tributary veins (n = 56). Adjunctive techniques during treatment included intraoperative elevation of the limb to greater than 45°, ultrasound mapping and digital occlusion of large perforator veins, limitation of foam volume per session, injection of sterile saline before treatment, and compression of the limb in the elevated position. The preoperative Venous Clinical Severity Score was 11.4 and decreased after treatment to 9.7. The immediate closure rate was 95% with 81% overall symptomatic relief at last follow-up. The mean follow-up was 113.5 days for the entire cohort; two limbs (1.5%) required postoperative anticoagulation for thrombus extension into the deep venous system (common femoral vein n = 1; popliteal vein n = 1) postoperatively for a mean of 22 days. Both resolved with anticoagulation. One asymptomatic limb developed a femoral vein deep venous thrombosis and one symptomatic late deep venous thrombosis was noted 4 months after the procedure. Postoperative pain and phlebitis were reported in 15.6% and 14.8% of patients, respectively, and all had resolved at last follow-up. No pulmonary emboli were noted and no neurologic or visual adverse events were recorded. CONCLUSIONS: Adjunctive techniques during microfoam ablation decreased thrombotic complications in our series compared with those reported in earlier phase III clinical trials. Excellent early closure and symptomatic improvement were also noted. Endovenous microfoam ablation with Varithena is a safe and effective nontumescent, nonthermal alternative to laser and radiofrequency ablation.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Jimenez JC, Lawrence PF, Woo K, et al. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33248297. doi:10.1016/j.jvsv.2020.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。